Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Immunoglobulin A Nephropathy
Clinical trial register · Taiwan

Immunoglobulin A Nephropathy Trials in Taiwan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2861 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:18 UTC
2861
Studies in scope
all four open statuses
1565
Recruiting now
open to new participants
340
Lead sponsors
across recruiting studies
Top sites
Taipei 8 New Taipei City 5 Kaohsiung City 4 Keelung 3 Taichung 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Immunoglobulin A Nephropathy trials in Taiwan

8 of 2861 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
NCT07498335Berger Disease, Bergers Disease, IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
28
Taipei, Taoyuan
2026-08-06
Recruiting
Study of Ravulizumab in Pediatric Participants With Primary IgAN
NCT07024563IgAN, IgAVN, Immunoglobulin A Nephropathy, Immunoglobulin A Vasculitis Associated Nephritis
Alexion Pharmaceuticals, Inc.
Phase 3
36
Taipei, Taoyuan
2025-06-14
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
New Taipei City, Taichung, Taipei
2024-08-30
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
Alexion Pharmaceuticals, Inc.
Phase 3
584
Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2024-03-29
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Keelung, Changhua County, Hsinchu, Hualien City, Kaohsiung City, Tainan, Taipei
2023-07-06
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Kaohsiung City, Keelung, New Taipei City, Taipei
2022-04-05
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Kaohsiung City, Keelung, New Taipei City, Taichung, Taipei
2022-03-15
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
404
Changhua, Hsinchu, New Taipei City, Taipei
2020-12-11
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-taiwan/condition/immunoglobulin-a-nephropathy

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,861 studies in total at the last sync on 15 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies listing the condition Immunoglobulin A Nephropathy.

How many Immunoglobulin A Nephropathy trials are recruiting in Taiwan?

2 of the 8 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Immunoglobulin A Nephropathy), 8 studies
PhaseStudiesRecruitingShare
Phase 37287.5%
Phase 2/31012.5%

Most active sponsors

Lead sponsors with the most studies (Immunoglobulin A Nephropathy)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals31
Alexion Pharmaceuticals, Inc.21
Otsuka Pharmaceutical Development & Commercialization, Inc.20
Alpine Immune Sciences Inc, A Subsidiary of Vertex10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.